Skip to main content
MJFF in the News

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    Global charities join forces to drive forward new drug for Parkinson’s

    Leading charities have provided biopharma company Neurolixis joint funding to test a new drug to reduce dyskinesia in people with Parkinson’s New drug holds potential to reduce dyskinesia, a common…

  • Default content image

    The Michael J. Fox Foundation for Parkinson’s Research Confers the Edmond J. Safra Humanitarian Award on Lily Safra in Recognition of Leadership Philanthropy

    NEW YORK (November 23, 2020) — The Michael J. Fox Foundation for Parkinson's Research (MJFF) today announces it has created the Edmond J. Safra Humanitarian Award to honor Lily Safra, chairwoman of…

  • Default content image

    Michael J. Fox Foundation Honors Caroline Tanner, MD, PhD, with Robert A. Pritzker Prize for Leadership in Parkinson's Research

    NEW YORK (November 19, 2020) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded the 2020 Robert A. Pritzker Prize for Leadership in Parkinson's Research to Caroline Tanner,…

  • Default content image

    Michael J. Fox Foundation Honors William Dauer, MD, with Bachmann-Strauss Prize for Excellence in Dystonia Research

    NEW YORK (November 19, 2020) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has announced William Dauer, MD, director of the Peter O’Donnell Jr. Brain Institute and professor of…

  • Default content image

    Michael J. Fox Foundation Announces $380,000 In Funding To Extend The California Parkinson's Disease Registry Through June 2021

    NEW YORK, NY; NOVEMBER 12, 2020 — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced today it is granting $380,000 in extension funding to the California Parkinson’s Disease…

  • Default content image

    The Michael J. Fox Foundation for Parkinson’s Research Sponsors Virtual Educational Course to Cultivate Additional Parkinson’s Clinicians

    NEW YORK, October 12, 2020 — Responding to the urgent need for additional specialists to treat the growing prevalence of people with Parkinson’s disease (PD), the International Parkinson and Movement…

  • Default content image

    Michael J. Fox Foundation and Acadia Pharmaceuticals Partner to Share Resources and Foster Dialogue on Cognitive Changes and Other Non-Motor Symptoms in Parkinson’s Disease

    Partnership provides educational resources on navigating cognitive changes to people with Parkinson’s and their care partners Among the estimated 6 million people worldwide with Parkinson’s, many…

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.